During the past decade, Asante Health System conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 9 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asante Health System" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "GOG Foundation" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asante Health System" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Asante Health System" are "Breast Adenocarcinoma" (2 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "HER2/Neu Positive" (2 trials), "Progesterone Receptor Positive" (2 trials) and "Recurrent Breast Carcinoma" (2 trials). Many other conditions were trialed in "Asante Health System" in a lesser frequency.

Most popular intervention types in "Asante Health System" are "Drug" (11 trials), "Other" (10 trials), "Biological" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (5 trials), "Bevacizumab" (4 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Asante Health System" are 6 trials for "Female" genders, 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Asante Health System". undefined are not yet recruiting, undefined are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Asante Health System, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Asante Health System, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".